Andrić, Zoran

Tip

Godina

89 2000 - 2027

Mp-kat.

Date issued - custom

Year from:

Year to:

Results 21-40 of 89 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2023	Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study	Kotecha, R; ...; Andric, Zoran G ; ...; (broj, koautora 20)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2023	Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study	Leal, Ticiana; ...; Andric, Zoran G ; ...; (broj, koautora 20)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2023	Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results	Liu, SV; ...; Andric, Zoran G ; ...; (broj, koautora 24)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2023	TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study	Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 25)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC	Ciardiello, F; Feng, Z; Smith, NR; Andric, Zoran G ; Shell, S; Yablonovitch, A; Guezel, G; Scheuenpflug, J	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	Perioperative bevacizumab in the treatment of colorectal cancer in patients with liver metastases	Nikolić, Ivan ; Manojlović, Nebojša ; Andrić, Zoran ; Radosavljević, Davorin ; Ristić, Marija; Kovčin, Vladimir	Naučni članak	51M51 - Vodeći nacionalni časopis kategorije M51
2022	Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100	Reck, M; ...; Andric, Zoran G ; ...; (broj, koautora 19)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin (R)) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)	Ohe, Yuichiro; ...; Andric, Zoran G ; ...; (broj, koautora 17)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer	Verschraegen, Claire; Andric, Zoran G ; ...; (broj, koautora 20)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	HERIZON overall survival results: A study of IMU-131, a HER2 targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2 overexpressing metastatic or advanced gastric/GEJ cancer	Maglakelidze, Marina; Ryspayeva, D; Andric, Zoran G ; Petrovic, Zeljko M; Bulat, IV; Nikolic, Ivan V ; Chawla, T; Nagarkar, R; Wiedermann, Ursula; Blumenstein, BA; Chong, LMO; Ede, NJ; Nixon, B; Good, AJ;	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2022	Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial	Verschraegen, Claire; Andric, Zoran G ; Moiseenko, Fedor; Makharadze, Tamta; Shevnya, Sergii; Oleksiienko, Alona; Ruiz, Eduardo Yanez; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong; Park, Sijin; Ju, Hana; Ohe, Yuichiro;	Naučni članak	21aM21a - Vodeći međunarodni časopis kategorije M21a
2022	Overweight and obesity in polycystic ovary syndrome: Association with inflammation, oxidative stress and dyslipidaemia	Perović-Blagojević, Iva; Vekić, Jelena ; Macut, Đuro ; Ignjatović, Svetlana ; Miljković-Trailović, Milica ; Zeljković, Aleksandra ; Spasojević-Kalimanovska, Vesna ; Božić-Antić, Ivana ; Bjekić-Macut, Jelica ; Kastratović-Kotlica, Biljana ; Andrić, Zoran ; Ilić, Dušan; Kotur-Stevuljević, Jelena ;	Naučni članak	22M22 - Međunarodni časopis kategorije M22
2022	Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2	Goel, Shom; Tan, Antoinette R; Rugo, Hope S; Aftimos, Philippe; Andric, Zoran G ; Beelen, Andrew Paul; Zhang, Jingshan; Yi, John S; Malik, Rajesh K; O'Shaughnessy, Joyce	Naučni članak	22M22 - Međunarodni časopis kategorije M22
2022	Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial	Peters, Solange; ...; Andric, Zoran G ; ...; (broj, koautora 26)	Naučni članak	21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2021	A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.	Maglakelidze, Marina; ...; Andric, Zoran G ; Nikolic, Ivan V ; ...; Radosavljevic, Davorin Z ; Petrovic, Zoran; ...; (broj, koautora 17)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2021	Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC	Jassem, Jacek; ...; Andric, Zoran G ; ...; (broj, koautora 19)	Naučni članak	21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2021	First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)	Andric, Zoran G ; ...; Stojanovic, Goran; Petrovic, Marina D ; ...; (broj, koautora 20)	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2021	Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies	Weiss, Jared; Goldschmidt, Jerome; Andric, Zoran G ; Dragnev, Konstantin H; Gwaltney, Chad; Skaltsa, Konstantina; Pritchett, Yili; Antal, Joyce M; Morris, Shannon R; Daniel, Davey	Naučni članak	21M21 - Vodeći međunarodni časopis kategorije M21
2021	Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.	Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G ; Bondarenko, Igor N; Shevnia, Serhii; Zaric, Bojan ; Bellala, Ravishankar; Charoentum, Chaiyut; Perez, Luis; Bullo, Felicitas; Garcia, Fernanda;	Konferencijski rad	Mp kategorija će biti prikazana naknadno.
2021	A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression	Andric, Zoran G ; Ceric, Timur; Rancic, Milan H ; Jakopovic, Marko; Aix, S Ponce; Ramlau, Rodryg; Ulanska, M; Caldwell, C; Ferrari, D; Annis, A; Vukovic, V; Zaric, Bojan ;	Konferencijski rad	Mp kategorija će biti prikazana naknadno.